Spotlight

Opioid Addiction Added to Eligible Conditions

Governor Murphy announced the addition of opioid addiction to the Medicinal Marijuana Program as an eligible condition. The MMP will have expanded availability by allowing for the use of medical cannabis as an adjunct to Medication Assisted Treatment (MAT) for all patients that suffer from opioid addiction, not only those with chronic pain.

The addition of opioid use disorder as a qualifying condition comprises a revision to the Final Agency Decision on new qualifying conditions first issued by DOH Commissioner Shereef Elnahal on March 22, 2018.

Learn More

Applicants Selected to Continue with ATC Approval Process

Applicants Selected to Continue with ATC Approval Process

The Department of Health has selected six applicants to continue with the approval process to open an alternative treatment center (ATC).

View Selected Applicants

Medicinal Marijuana Program Now Serves 43,082 Patients

Following the addition of new qualifying medical conditions as well as lowered patient and caregiver fees, the Medicinal Marijuana Program has seen the number of patients in the program more than double since the day Governor Murphy took office in January. The program now serves more than 43,000 patients in New Jersey.

Read More

NJ Medical Marijuana Dispensaries May Post Prices

NJ Medical Marijuana Dispensaries May Post Prices

Learn about this change and other developments in the Medicinal Marijuana Program.

More

Annual Report Now Available

The Medicinal Marijuana Program has finalized its annual report for the calendar year 2017.

View Annual Report

Executive Order 6 Report

Executive Order 6 Report

In accordance with Executive Order 6, issued by Governor Phil Murphy on January 23, 2018, Commissioner Shereef Elnahal of the Department of Health has published a report on the Department's review of the Medicinal Marijuana Program.

Read the Report

Overview

Overview

The Department of Health is committed to implementing the Compassionate Use Medical Marijuana Act. On this website you will find guidance for patients, physicians, alternative treatment center operators, and residents.

Overview Poster

2018 ATC RFA Document Library

Following a request for ATC applications in summer 2018, the Department selected six applicants to continue the ATC approval process in December 2018.

Read Press Release

Document Library

Medicinal Marijuana Patient Overview

The Department has added five new categories of debilitating conditions effective March 27, 2018, which will expand the number of patients eligible to participate in the Medicinal Marijuana Program. Interested in how the program works but are not sure where to start? Learn about the patient process with our printable overview poster.

Grand Rounds Lecture Series

Dr. Shereef Elnahal, Commissioner of Health, continues to deliver Grand Rounds lectures to doctors and other health professionals to discuss the MMP. Those lectures have focused on evidence that supports marijuana as an appropriate treatment for patients with certain debilitating conditions.

Contact Us

Medicinal Marijuana Registry

E-Mail the Medicinal Marijuana Program

Contact our Customer Service Unit at: 609-292-0424

Frequently Asked Questions

Use the following links to find answers to the MMP's most frequently asked questions. Due to the development of the program, questions and answers are subject to change. Visit this section periodically to stay updated with current information.

Last Reviewed: 3/20/2019